Author
Nenad Prodanović
Also Known As
N Prodanovic, N. PRODANOVIC, N. Prodanovic, Nenad Prodanovic, Nenad Prodanović
24
Publications
1.6K
Citations
12
H-Index
28
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 4 | 4 | 151 |
2 | Health Sciences | 2 | 2 | 97 |
3 | Endocrinology | 2 | 2 | 62 |
4 | Public Health | 1 | 1 | 56 |
5 | Immunology | 1 | 1 | 48 |
Nenad Prodanović
×
15
Publications
1.6K
Citations
12
H-Index
| Year | Citations | |
|---|---|---|
2013 | 650 | |
2016 | 278 | |
2015 | 165 | |
Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition study | 2017 | 121 |
2010 | 56 | |
2013 | 56 | |
2017 | 54 | |
2019 | 48 | |
2010 | 41 | |
2010 | 37 |
Page 1
Page 1